The Annals Take our Readership Survey!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


Drug Intelligence & Clinical Pharmacy: Vol. 22, No. 3, pp. 209-211.
© 1988 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dayal, S.
Right arrow Articles by Watson, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dayal, S.
Right arrow Articles by Watson, W.


Research Articles

Unpredictable anaphylactic reaction to protamine sulfate

SK Dayal, JC Barlow, and WA Watson

Anaphylactic reactions to protamine administration often can be predicted by the presence of patient risk factors. In the case described, an anaphylactic reaction to protamine occurred in a patient without identifiable risk factors. A history of prior protamine exposure, fish allergy, or vasectomy suggests patients may be at greater risk for anaphylactic response to protamine; however, patients can develop anaphylaxis in the absence of such factors.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. E. Kimmel, M. A. Sekeres, J. A. Berlin, N. Ellison, V. J. DiSesa, and B. L. Strom
Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass
J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1916 - 1922.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. D. Williams, M. N. D'Ambra, T. E. Maione, K. E. Lynch, and D. F. Keene
Recombinant platelet factor 4 reversal of heparin in human cardiopulmonary bypass blood
J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 975 - 983.
[Abstract] [Full Text]




homecopy help contact us subscription past issues search current issue
Copyright © 1988 by Harvey Whitney Books Company.